FDA grants de novo authorization to ArteraAI Prostate
FDA grants priority review to gepotidacin for uncomplicated urogenital gonorrhea
Pearls & Perspectives: Bringing the Magic Back to Medicine, with David Canes, MD
Perioperative EV plus pembrolizumab significantly extends EFS, OS in MIBC